Nicoccino develops the product for international companies that wish to establish themselves in the market of licensed nicotine products, alternatively, want to expand their existing product portfolio and that are financially equipped to reach out globally or to selected regions. The Company has therefore not the intention to sell the drug for smoking cessation, which is now under development, ourselves.
The consumer product Nicoccino™ is currently sold through the company's e-commerce site, www.purenicoccino.com.
[Q3 INTERIM REPORT, JANUARY – SEPTEMBER 2016, NICOCCINO HOLDING AB]
The sales online continues in the same pace as during previous quarters. Different campaigns have been conducted in order to drive sales of the existing stock.
The products now available for sales has a shelf life until January 2017. Thereafter all sales activities of Nicoccino™ in its current form – a consumer product – will end. Instead, the nicotine strip can be sold as a NRT (Nicotine Replacement Therapy) after completed study and approval from the MPA (Medical Products Agency).